July 2017

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


NEW
Due Dates To Be Announced All Ranks Non-Federal Included in Advance Announcements

State of Florida
Department of Health
Biomedical Research Programs
Bankhead-Coley Cancer Research Program
James & Esther King Biomedical Research Program

Advance Announcement

The Florida Department of Health released advance announcements for the Bankhead-Coley Cancer Research Program and the James & Esther King Biomedical Research Program.   Both advance notices for these funding can be viewed at FDOH Funding Opportunity Announcements.  The advance announcements include information about the funding mechanisms to be offered, as well as the funding amounts and performance periods.  

The final announcements are scheduled to be issued by the end of June and will include the final detailed information for these programs


Open All Ranks Non-federal Clinical Trials

The Gateway for Cancer Research
Research Grants

 
Gateway focuses on transformational science via effective clinical trials - when basic science translates into human testing and clinical practice.
Due Dates: Rolling requests for funding conducted in two stages: a Letter of Intent (LOI) and if invited, a full application. Applicants must submit via Gateway's Grant Management System  
Amount & Project Period: Funding is variable and duration is 1 to 3 years
Eligibility: All Ranks
Contact: Gateway Contacts are: Jerian Dixon-Evans, Research Grants Specialist  Jerian.Dixon-Evans@gatewaycr.org (847) 342-7361 and Domarina Oshana, Ph.D., Director of Research and Grants Domarina.Oshana@gatewaycr.org (847) 342-7443
Link: Grant Application Process


Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research
W911NF-17-S-0002 01
April 2017 - 31 March 2022

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding. Whitepapers and proposals will be evaluated only if they are for fundamental scientific study and experimentation directed toward advancing the scientific state of the art or increasing basic knowledge and understanding. 
Due Dates: Open until Mar. 31, 2022
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W911NF-17-S-0002


Ongoing Postdocs/Junior Faculty Non-federal Pediatric Brain Tumors

A Kids' Brain Tumor Cure Foundation (aka The PLGA Foundation)
Research Grants

Proposals related to basic and translational projects that can advance understanding of the underlying biology of the development and treatment of pediatric low grade glioma brain tumor (PLGA) tumors will be considered.
Due Dates: Letters of Intent are accepted on an ongoing basis, and are reviewed by an expert panel. Based on this feedback, selected applicants will be invited to submit a full proposal
Amount & Project Period: Funding is based on size, complexity, and potential impact of project, and can be awarded over a one-, two-, or three-year period.
Eligibility: Investigators in the early years of their careers are encouraged to apply.  
Contact: Office of Sponsored Research (x6804)
Link: Apply for an AKBTC Sponsored Grant
September 30, 2017 All Ranks Federal Medical Research


Department of Defense - Dept. of the Army - USAMRAA
DoD USAMRMC FY17 Broad Agency Announcement
for Extramural Medical Research
XW1XWH-17-R-BAA1

Projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed towards advancing the state of the art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution.
Due Dates: This Broad Agency Announcement (BAA) is open from October 1, 2016 through September 30, 2017, 11:59 p.m., ET. Pre-proposals are required so that the Government can determine whether a proposed research idea meets USAMRMC's mission and requirements. Pre-proposals may be submitted at any time during the 12-month period.  To submit a full proposal/application, the PI must have received an invitation to submit from a Contracting or Grants Officer.
Amount & Project Period: No  funding limitations specified - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-R-BAA1
Various NCI

Multiple See Below Federal Cancer Moonshot

Cancer Moonshot - Funding Opportunities

NCI has identified funding opportunity announcements (FOAs) from within its extensive research portfolio that address the goals of the Cancer Moonshot.   This portfolio will expand over the next 7 years.  Planning for implementation of longer-term scientific initiatives is underway.  Multiple ways to fund the best science, including grants, supplements and other mechanisms are being considered.
Due Dates: Multiple - See specific FOA
Amount & Project Period: See specific FOA
Eligibility: See specific FOA
Contact: Office of Sponsored Research (x6804)
Link: Cancer Moonshot Funding Opportunities


June 21 (Pre-application) See Below Federal Ovarian

Congressionally Directed Medical Research Programs
Ovarian Cancer Research Program (OCRP)

 
Due Dates: June 21 (Pre-application)
Invited Applications: Sept. 04 (OSR) Ι Sept. 06 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: Program Announcements Ι Pre-application Site
 

Ovarian Cancer Academy - Early-Career Investigator Award
W81XWH-17-OCRP-OCA  

This Program Announcement solicits Early-Career Investigators to join the existing Ovarian Cancer Academy. This award enables the Early-Career Investigator (PI on application) to pursue an ovarian cancer project that may be basic, translational, and/or clinical research, under the guidance of a Designated Mentor. The Designated Mentor is not required to be at the same institution as the Early-Career Investigator.
Amount & Project Period: $725,000 (Direct Costs) - 4 years
Eligibility: Must be w/in 3 years of last postdoctoral research position (Ph.D.) or clinical fellowship (M.D.), or equiv. as of full application submission deadline.
NOTE:  An eligibility letter is required w/submission of both pre-application and full application.
May be a research- or physician-scientist;
Must not have a concurrent Career Development-like award at time of award;
Must have an institutional commitment of approximately 50% protected time for ovarian cancer research and Academy activities including participation in monthly webinars;
Must commit no less than 25% effort for first 2 years.
PA Link: W81XWH-17-OCRP-OCA
 

Clinical Development Award
W81XWH-17-OCRP-IIRA

The goal of this award is to accelerate clinical introduction of medical products and technologies targeting ovarian cancer biology. Near-term clinical impact is expected. Proof of concept demonstrating the potential utility of the proposed product or a prototype/ preliminary version of the proposed product should already be established; thus, preclinical studies in animals are not allowed. Small-scale clinical trials (Phase 0, Phase 1, Pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed. Relevant data, either published or unpublished, that support the study rationale are required.
Amount & Project Period: $600,000 (Direct Costs) - 3 years
(Optional Early-Career Investigator: If requesting an optional nested Early-Career Investigator, an additional $200,000 is allowed to support this investigator.)
Eligibility: Must be at or above the level of Assistant Professor (or equiv.) Optional nested Early-Career Investigator:  Must be w/in 5 years of last postdoctoral research position, and can only be selected if a clinical trial is being proposed.
PA Link: W81XWH-17-OCRP-CDA
 

Investigator-Initiated Research Award
W81XWH-17-OCRP-IIRA

This award is intended to support high-impact research that has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials.
Amount & Project Period: $450,000 (Direct Costs) - 3 years
Eligibility: Must be at or above the level of Assistant Professor (or equiv.)
PA Link: W81XWH-17-OCRP-IIRA




June 26 (LOI) All Ranks Non-federal Breast

National Comprehensive Cancer Network and Pfizer Independent Grants for Learning & Change (IGLC)
2017 Clinical Pathways in Breast Cancer

This new initiative solicits proposals using clinical pathways to address a quality improvement (QI) initiative along the continuum of care for breast cancer patients.  Letters of Intent are encouraged that describe concepts and ideas for developing, implementing and evaluating guidelines-based clinical pathways in breast cancer.
Due Dates: June 26 (Letter of Intent)
Invited Applications Due:  Sept. 21 (OSR) Ι Sept. 25 (Sponsor)
Amount & Project Period: Not Stated
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview | RFP | Pfizer, Inc. Grant Application System



June 27 (NOON) All Faculty Ranks Non-federal Immune Therapy

SU2C Catalyst Research Grants: Genentech-Supported

The SU2C Catalyst establishes a mechanism through which industry and academic scientists in the cancer community will conduct SU2C collaborative research projects that will deliver significant benefits for patients and society, accelerating the development of new treatments and, where appropriate, combination therapies.  It takes a structured and prioritized approach to early-phase clinical studies and translational research in order to accelerate the time to get new treatments to patients.  As the Scientific Partner in the SU2C Catalyst, the American Association for Cancer Research (AACR) provides scientific oversight and conducts expert peer review and grants administration for SU2C. 
Due Dates: June 23 (OSR) Ι June 27 (Sponsor)
Amount & Project Period: $ 3,000,000.00 - 3 years
Eligibility: All Faculty Ranks - Multi-investigator, multi-institutional projects are required.
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι proposalCENTRAL



June 28 (Pre-application) See Below Federal Lung

Congressionally Directed Medical Research Programs
Lung Cancer Research Program (LCRP)

Due Dates: June 28 (Pre-application)
Invited Applications Due:  Sept. 25 (OSR) Ι Sept. 27 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: Program Announcements Ι Pre-application Site

Idea Development Award
W81XWH-17-LCRP-IDA

This mechanism promotes new ideas still in early stages of development and having potential to yield impactful data and new avenues of investigation. It supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths from lung cancer. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.
Amount & Project Period: $350,000 (Direct Costs) - 2 years
Eligibility: Investigators may be eligible for both New Investigator and Established Investigator categories, and choice of application category is at the PI's discretion, but only 1 application is allowed.  
Established Investigator:
Must be an independent investigator at or above the level of Assistant Professor (or equiv.);
New Investigator: By application due date, must have:
Not previously received an LCRP Idea Development Award or LCRP Early Investigator Synergistic Idea Award; and
Must be an independent investigator at or above Asst. Professor (or equiv) and w/in10 years of first faculty appointment (or equiv.) by due date.
PA Link: W81XWH-17-LCRP-IDA
 

Investigator-Initiated Translational Research Award
W81XWH-17-LCRP-IITRA

This mechanism supports translational research that will develop promising ideas in lung cancer into clinical applications. Research plan must involve a reciprocal flow of ideas and information between basic and clinical science, such as studies advancing/translating in vitro and/or animal studies to applications with human samples/cohorts; late-stage preclinical work leading to/preparing for a clinical trial; or correlative studies associated with an ongoing or completed clinical trial and projects that develop endpoints for clinical trials.
Amount & Project Period: $400,000 (Direct Costs) - 2 years
Eligibility: All Ranks
PA Link: W81XWH-17-LCRP-IITRA
 

Translational Research Partnership Award
W81XWH-17-LCRP-TRPA

This mechanism supports partnerships between clinicians and research scientists that will accelerate movement of promising ideas in lung cancer into clinical applications. The intention is to fund a broad range of translational studies, including: studies advancing/translating in vitro and/or animal studies to applications with human samples/cohorts; late-stage preclinical work leading to/preparing for a clinical trial;  Pilot, proof-of-principle clinical trials (must include documentation of an existing IND or Investigational Device Exemption (IDE), if applicable); or correlative studies associated with an ongoing or completed clinical trial and projects that develop endpoints for clinical trials.
Amount & Project Period: $900,000 (Direct Costs) - 3 years
Eligibility: All Ranks - One partner in the collaboration must be a research scientist and the other must be a clinician.
PA Link: W81XWH-17-LCRP-TRPA

NEW
June 29 See Below Non-Federal Prevention

Prevent Cancer Foundation
2017 Research Grant and Fellowship Cycle

Grant or Fellowship proposals will be considered in the following categories:
       Basic, clinical, translational and population-based research projects;
       Education programs in cancer prevention/early detection; Early detection projects; or
       Behavioral intervention projects
An eligible proposal must demonstrate substantial potential for impact on prevention/early detection of cancer.
Due Dates: June 27 (OSR) Ι June 29 (Sponsor)
Note:  There is a $75 application fee associated with each submission.  See Guidelines for information.
Amount & Project Period: $100,000 - 2 years (Grant or Fellowship)
Eligibility: Grants: All Ranks
Fellowships: Postdoctoral level only
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Grant Guidelines Ι Fellowship Guidelines  proposalCENTRAL


NEW
June 30
(Pre-Application)		 See Below Federal Cancer Research

Congressionally Directed Medical Research Program
Peer Review Cancer Research Program (PCRP)

Due Dates: June 30 (Pre-application)
Invited Applications Due: Sept. 26 (OSR) Ι Sept. 28 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: PRCRP Program Announcements
 

Idea Award with Special Focus

This mechanism supports innovative, untested, high-risk/ potentially high-reward concepts, theories, paradigms, and/or methods in cancer research that are relevant to active duty Service members, Veterans, other military beneficiaries, and the American public. The proposed research approach should be innovative. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.
Amount & Project Period: $400,000 (Direct Costs) - 2 years
Eligibility: Must have a faculty level appointment (or equivalent)
PA Link: W81XWH-17-PRCRP-IA
 

Translational Team Science Award

This mechanism supports hypothesis-driven translational studies. These studies should be associated with an ongoing or completed clinical trial and/or annotated biorepositories and focused on research for the next-phase clinical trial or future clinical application.
Amount & Project Period: $1,000,000 (Direct Costs) - 4 years  
Eligibility: Initiating & Partnering PI must be at or above the level of Assistant Professor or equivalent.
It is encouraged that at least one of the PIs be a military or VA investigator.
PA Link: W81XWH-17-PRCRP-TTSA


June 30 All Ranks Non-federal Children's Leukemia

Children's Leukemia Research Association (CLRA)
Research Grants

These research grants will be made for the most promising research into leukemia, in the hopes of isolating the causes and finding a cure for this dread disease.
Due Dates: June 28 (OSR) Ι June 30 (Sponsor)
Amount & Project Period: $30,000 -1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview and Application
Lung Cancer Research
Foundation
July 01 All Ranks Non-federal Lung

Lung Cancer Research Foundation
Grant Program

This program provides funding for innovative research focused on the prevention, diagnosis, treatment and cure of lung cancer.
Due Dates: June 29 (OSR) Ι Jul. 01 (Sponsor)
Amount & Project Period: $150,000 - 2 years
Eligibility: Individuals must fall into one of the following categories: Students and fellows Young and mid-career investigators with less than ten years' experience since initial faculty appointment Non-tenure track researchers, staff scientists, and clinicians. Senior investigators with more than ten years' experience since faculty appointment are not eligible for LCRF funding but are encouraged to mentor a junior team member through the application process.
Contact: Office of Sponsored Research (x6804)
Link: Guidelines




July 01 ALL Ranks (see below) Non-federal Clinical Oncology

SWOG Early Exploration and Development (SEED) Fund

This fund encourages preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN).   Awards may assist investigators with projects supporting the following types of studies: pre-clinical data, secondary data analysis from clinical trials, pilot and feasibility studies (including early stage clinical trials), small, self-contained research projects, or development of research methodology/technology.
Due Dates: June 29 (OSR) Ι Jul. 01(5:00, pm ET) (Sponsor)
Additional Due Date:  Dec. 01, 2017
Amount & Project Period: $50,000 (Direct Costs) - 1 to 2 years
Eligibility: Any SWOG investigator eligible for NIH funding
Contact: Office of Sponsored Research (x6804)
RFA Link: Overview Ι 2017 RFA


July 01 Postdocs Non-federal Career Development

The Helen Hay Whitney Foundation
2017 Research Fellowship

This fellowship supports early postdoctoral research training in all basic biomedical sciences.
Due Dates: June 29 (OSR) Ι July 01 (Sponsor)
Amount & Project Period: Yr. 01:  $52,000 (Stipend) + $1,500 (Allowance)
Yr. 02:  $54,000 (Stipend) + $1,500 (Allowance)
Yr. 03:  $57,000 (Stipend) + $1,500  (Allowance)
Eligibility: Must have obtained or be in final stages of obtaining a Ph.D., M.D., or equiv.
Must not have more than 1 year of postdoctoral research experience at deadline for submitting application and who have received a PhD (or D.Phil. or equiv.) no more than 2 years before the deadline, or M.D. degree no more than 3  years before the deadline.
No more than one application from a laboratory during each annual cycle.  Applications from different laboratories/supervisors at the same institution are allowed.
Contact: Office of Sponsored Research (X6804)
Link: Research Fellowships

July 03 All Ranks Non-federal Cutaneous

American Society for Dermatologic Surgery
Cutting Edge Research Grant Program (CERG)

Submission of well-conceived research projects that stimulate advancement of the practice of dermatologic surgery, the invention of new technologies or research projects that document the outstanding and high volume work of dermatologic surgeons are encouraged.  Specifically encouraged are proposals in the areas of depth of training, scope of practice, safety and efficacy as well as research with specific relevance in Core surgical procedures and techniques; Cutaneous oncology; and new technologies.
Due Dates: June 29 (OSR) Ι Jul. 03(Sponsor)
Amount & Project Period: $20,000  
Eligibility: All Ranks - PD/PI must be ASDS member
Contact: Office of Sponsored Research, x6804
Link: Overview Ι Application Site
R25 NIH
NCI is a participating Institute
July 04 (LOI) All Ranks Federal BD2K Educ. resources

BD2K Open Educational Resources for Skills Development in Biomedical Big Data Science

This FOA will support creative educational activities with a primary focus on Courses for Skills Development for biomedical researchers who need the requisite knowledge and skills to extract knowledge from biomedical Big Data.
Due Dates: Jul. 4 (Letter of Intent)
Applications Due:  Jul. 31 (OSR) Ι Aug. 02 (Sponsor)
Amount & Project Period: Not to exceed $200,000/yr. (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-HG-16-016
Companion RFAs: RFA-ES-16-002,  BD2K Mentored Career Development Award in
                             Biomedical Big Data Science for Clinicians
                             and Doctorally Prepared Scientists (K01)
RFA-ES-16-003,  BD2K Career Transition Award in Biomedical
                             Data Science for Intramural Investigators
                             (K22)
RFA-LM-16-002, Predoctoral Training in Biomedical Big Data
                             Science (T32)

July 06 Faculty Ranks Non-federal Career Development

Damon Runyon Cancer Research Foundation
Innovation Award

The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances.
Due Dates: Jul. 03 (OSR) Ι Jul. 06 (Sponsor)
Amount & Project Period: $300,000 - 2 years (Stage 1 award will be for two years;  Stage 2 support for years 3 & 4 will be granted to those awardees who demonstrate progress on the proposed research during years 1 & 2 of the award.) 
Eligibility: Applicants must belong to one of the following categories: Tenure-track Assistant Professors w/in first four years of obtaining initial Assistant Professor position. (Cut-off date: July 1, 2013);
Clinical Instructors and Senior Clinical Fellows (in final year of sub-specialty training) holding an MD and pursuing a period of independent research before taking a tenure-track faculty position, and must have dedicated laboratory space and support of institution;
Not eligible are Research Assistant Professors, Research Associate Professors, Research Scientists and Postdoctoral Fellows; 
Applicants are expected to commit at least 80% of their full time effort to conducting research.
See award overview for additional eligibility details.
Contact: Office of Sponsored Research (x6804)
Links: Application Guidelines


NEW
July 07
(Pre-Application)		 See Below Federal Prostate

Congressionally Directed Medical Research Programs
Prostate Cancer Research Program (PCRP)

Due Dates: Jul. 07 (Pre-application)
Use eBRAP (for pre-application submissions)
Invited Applications:  Sept. 26 (OSR) Ι Sept. 28 (Sponsor)
Note:  Confidential letters of recommendation are due October 03
Contact: Office of Sponsored Research (x6804)
Link: PCRP Program Announcements
 

Health Disparity Research Award
W81XWH-17-PCRP-HDRA

This award is intended to support research that demonstrates the potential to have a major impact on an area of paramount importance in prostate cancer. It is the responsibility of the PI to clearly and explicitly describe the potential impact of the proposed study on prostate cancer and to convey its level of significance.
Amount & Project Period: New Investigator Option: $450,000
Qualified Collaborator Option: $600,000
Nested Young Investigator Option: $92,500 for a predoctoral investigator or $115,000 for a postdoctoral investigator to specifically support this option
Performance Period: 3 years
Eligibility: Established Investigators must be independent and at or above Asst. Professor (or equiv.) level;
New Investigators must be w/in 10 years of completing terminal degree by time of application submission;
Qualified Collaborator must be independent investigator at or above Asst. Professor (or equiv) level;
Nested Young Investigator Option:
Must meet eligibility requirements for one of the following categories:
     Predoctoral Ph.D., M.D. (or equiv) and M.D./Ph.D. (or  
     equivalent) investigators:   Be a graduate student enrolled full-time in an accredited doctoral program; and - will have successfully completed comprehensive examinations or otherwise met candidacy requirements by March 31, 2018;
     Postdoctoral Ph.D., M.D. (or equiv.) and M.D./Ph.D. (or  
     equivalent) investigators:   Will have successfully defended a doctoral thesis or possess an M.D. degree by March 31, 2018; and Will have 3 years or less of postdoctoral fellowship experience by March 31, 2018
Link: W81XWH-17-PCRP-HDRA
 

Impact Award
W81XWH-17-PCRP-IA

This award is intended to support research that demonstrates the potential to have a major impact on an area of paramount importance in prostate cancer. It is the responsibility of the PI to clearly and explicitly describe the potential impact of the proposed study on prostate cancer and to convey its level of significance.
Amount & Project Period: Single PI: $750,000 (Direct Costs)
Partnering PI Option: $2,000,000 (Direct Costs)
Performance Period: 3 years
Eligibility: Must be independent investigator at/above Asst. Professor (or equiv.) level for both single PI and Partnering PI options.
Link: W81XWH-17-PCRP-IA
R01 NCI

NEW
July 09 (LOI) All Ranks Federal HIV/Aids-Tumor Niche

HIV/AIDS and the Tumor Niche

The purpose of this FOA is to advance understanding of the role of the tumor niche or microenvironment in risks, development, progression, diagnosis, and treatment of cancer observed in individuals with an underlying HIV infection or Acquired Immune Deficiency Syndrome (AIDS).
Due Dates: Jul. 09 (Letter of Intent)
Aug. 03 (OSR) Ι Aug. 07 (Sponsor)
Additional due dates:  August 7, 2018
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-030
R01 NCI
Revision applications to active NIH R01 awardees.

NEW
July 11 All Ranks Federal Biomarker Assay Validation

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants

The purpose is to accelerate the pace of translation of NCI-supported methods/assays/technologies (referred to as "assays") to the clinic.  Specifically, the focus is on the adaption and clinical validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") for cancer detection, diagnosis, prognosis, monitoring, and prediction of response to treatment, as well as markers for cancer control and prevention.  Research applications may support acquisition of well-annotated specimens from NCI-supported or other clinical trials or observational cohorts/consortia for the purpose of clinical validation of the assay.
Due Dates: 30 days prior to due date (not required, but suggested)
Jul. 7 (OSR) Ι Jul. 11 (Sponsor)
Addnl. Due Dates:  Oct. 27, 2017.  Feb 27, Jul. 11, & Oct 26, 2018
Amount & Project Period: $150,000/yr. (Direct Costs) - Parent grant must be active when application is submitted. There must be a minimum 2 years of support remaining on parent award (not to include a no cost extension) at estimated time of award.
Eligibility: All Ranks - The PD(s)/PI(s) on the revision must be the PD(s)/PI(s) on the parent grant, but other PD(s)/PI(s) may be the leaders of the assay validation team.
Contact: Office of Sponsored Research (x6804)
Link: PAR-17-003




NEW
July 13 1:00pm/EDT See Below Non-Federal Team Science

AACR-Bayer Innovation and Discovery Grant

This program is designed to provide new treatment options for cancers with high unmet medical need, encourage innovation and translation of ideas from basic research into novel drugs, and foster collaborations between excellent academic groups and the pharmaceutical industry.  The program offers grants meritorious projects that examine novel (and druggable) targets and biomarkers.
Due Dates: Jul. 11 (OSR) Ι Jul. 13 (Sponsor)
Amount & Project Period: $25,000 - 1 year
Eligibility: All Faculty Ranks
AACR membership required
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι Application Instructions


July 13 (Pre-application) All Faculty Ranks federal Bone Marrow Failure

Congressionally Directed Medical Research Programs (CDMRP)
Bone Marrow Failure Research Program (BMFRP)
Idea Development Award
W81XWH-17-BMFRP-IDA

This award is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP vision of understanding and curing BMF diseases. This mechanism supports new ideas w/a high probability of revealing new avenues of investigation, and should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach.
Due Dates: July 13 (Pre-application) Pre-application Site
Invited Applications Due:  Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Amount & Project Period: $315,000 (Direct Costs) - 2 years
Eligibility: Established Investigators: Independent investigators at or above Asst. Professor (or equiv.) and 10 years or more from a terminal degree;
Early Career Investigators: Independent investigators at Assistant Professor, Instructor, or Assistant Research Professor (or equiv.) level and less than 10 years from terminal degree (excl. time spent in medical residency or during family medical leave) at time of application submission deadline Time spent as a postdoctoral fellow is not excluded and must be w/in 10-year span from the time of terminal degree.
Contact: Office of Sponsored Research (x6804)
Links: Program Announcements  Ι W81XWH-17-BMFRP-IDA


NEW
July 14
(Pre-Application)		 All Faculty Ranks Federal Prostate

Prostate Cancer Research Program (PCRP)
Idea Development Award
W81XWH-17-PCRP-IDA

This award supports new ideas representing innovative approaches to prostate cancer research. Applications should be based on a sound scientific rationale established through logical reasoning and/or critical review and analysis of the literature. Due the emphasis on innovation, presentation of preliminary data relevant to prostate cancer and proposed project is encouraged, but not required.
Due Dates: Jul. 14 (Pre-application)
Use eBRAP (for pre-application submissions)
Invited Applications: Oct. 24 (OSR) Ι Oct. 26 (Sponsor)
Amount & Project Period: New Investigator: $375,000 (Direct Costs)
Established Investigator: $600,000
Established Investigator-
Partnering PI Option: $1,000,000
Performance Period: 3 years
Eligibility: New Investigator:  Independent, early-career investigator w/in 10 years of completing terminal degree at time of application submission.
Established Investigator: Must be independent investigator at/above Asst. Professor (or equiv.) level.
Contact: Office of Sponsored Research (x6804)
Link: PCRP Program Announcements Ι W81XWH-17-PCRP-IDA
U01 NCI

July 14 All Ranks Federal Solid Tumor Therapies

Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy

The purpose is to invite applications proposing studies to enhance pre-clinical in vitro and in vivo testing of NCI-prioritized molecularly targeted anti-cancer agents for use with radiation therapy combined with systemic chemotherapy. Studies should generate validated high-quality preclinical data on the effects of molecular therapeutics when added to standard-of-care therapies for solid tumors. The specific purpose is to provide a more rational basis for prioritizing those NCI-supported investigational new drugs or agents (INDs) most likely to have clinical activity with chemo-radiotherapy.
Due Dates: Jul. 12 (OSR) Ι Jul. 14(Sponsor)
Additional Due Date:  Nov. 14, 2017
Amount & Project Period: Max. $450,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-111




July 15 Postdocs Non-federal See Below

Science and Scilife Lab Prize for Young Scientists

Recent doctoral graduates in the life sciences may submit a 1000-word essay based on their thesis work.  The categories are Cell and Molecular Biology; Genomics and Proteomics; Translational Medicine; and Ecology and Environment
Due Dates: July 15
Amount & Project Period: The winners will:
>Be published by Science
> Receive up to 30,000 USD in prize money
> Be honored in Stockholm, Sweden during Nobel week
Eligibility: Postdocs - Must have been awarded Ph.D. between January 1 2015 and December 31 2016 Prizes will only recognize work that was performed while entrant was a graduate student.
Contact: SciLifeLabPrize@aaas.org
Link: Overview/Guidelines/Contact Information
R01 NCI

July 18 (LOI) All Ranks Federal Inter-organelle Communication

Inter-organelle Communication in Cancer

The purpose of this FOA is to support research projects that examine how inter-organelle communication in cancer cells and/or tumor-associated cells affects cellular function, adaptation, and phenotypic plasticity.
Due Dates: Jul. 18 (Letter of Intent)
Applications Due:  Aug. 14 (OSR) Ι Aug. 16 (Sponsor)
Amount & Project Period: Application budgets not limited - 5  years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-203
Companion FOA: PAR-17-204 (R21)


NEW
July 25 (LOI) All Ranks Federal PCORI

Patient Centered Outcomes Research Institute
Cycle 2 2017 Funding Announcements

PCORI's Online System will open for Cycle 2 2017 PCORI Funding Announcements (PFA) on Friday, June 23, 2017.  The opportunities are:
1.    Pragmatic Clinical Studies to Evaluate Patient-Centered Outcomes - Cycle 2 2017
2.    Limited PCORI Funding Announcement: Dissemination and Implementation of PCORI-Funded Patient-Centered Outcomes Research Results and Products in Real-World Settings - Cycle 2 2017
3. Symptom Management for Patients with Advanced Illness - Cycle 2 2017
Due Dates: July 25 (Letter of Intent)
Invited Applications:  Oct. 23 (OSR) Ι Oct. 25 (Sponsor)
Amount & Project Period: See specific announcement
Eligibility: All Ranks, unless otherwise specified in announcement   
Contact: Office of Sponsored Research (x6804)
Link: Cycle 2 2017 Funding Announcements


NEW
July 27
(Pre-Application)		 See Below Federal Prostate/CDA

Congressionally Directed Medical Research Programs
Prostate Cancer Research Program (PCRP)
Due Dates: Jul. 27 (Pre-application)
Use eBRAP (for pre-application submissions)
Applications Due: Aug. 08 (OSR) Ι Aug. 10 (Sponsor)
Note:  Confidential letters of recommendation are due August 15th
Contact: Office of Sponsored Research (x6804)
Primary Link: PCRP Program Announcements

 

Early Investigator Research Award
W81XWH-17-PCRP-EIRA

This award is intended to support research that demonstrates the potential to have a major impact on an area of paramount importance in prostate cancer. It is the responsibility of the PI to clearly and explicitly describe the potential impact of the proposed study on prostate cancer and to convey its level of significance.
Amount & Project Period: $200,000 (Direct Costs) - 2 years
Eligibility: Postdoctoral PI must:
Have successfully defended a doctoral thesis or possess an M.D. degree (or equiv.) by March 31, 2018;
Be involved in an accredited postdoctoral training or medical residency program; and
Have 3 years or less of postdoctoral research experience (excluding clinical residency or clinical fellowship training) by March 31, 2018.
PA Link: W81XWH-17-PCRP-EIRA
 

Physician Research Award
W81XWH-17-PCRP-PRA

This Award supports a mentored research experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. The mentored physician is considered the Principal Investigator (PI) of the application.
Amount & Project Period: $520,000 (Direct Costs) - 4 years
Eligibility: PI must be a physician w/clinical duties and/or responsibilities and, at application submission deadline, is either:
In last year of an accredited graduate medical education program, either as a resident or fellow, or
w/in 3 years of having initiated first appointment as an Instructor, Asst. Professor, or equiv.
(Organization is required to provide at least 40% protection time for prostate cancer research, which can include effort dedicated to other prostate cancer research projects)
PA Link: W81XWH-17-PCRP-EIRA



July 27 (LOI) All Ranks Federal Lung

Lung Cancer Research Program (LCRP)
Concept Award
W81XWH-17-LCRP-CA

This mechanism supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to lung cancer.  Applications must describe how the new idea will enhance the existing knowledge of lung cancer or develop an innovative and novel course of investigation.
Due Dates: Jul. 27 (Letter of Intent)
Applications Due:  Aug. 08 (OSR) Ι Aug 10 (Sponsor)
Amount & Project Period: $100,000 (Direct Costs) - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Primary Link Ι W81XWH-17-LCRP-CA Ι Pre-application Site


NEW
August 01 (LOI) See Below Non-Federal General Research Support

American Cancer Society
Clinical Research Professor Awards

These grants provide flexible funding for established investigators in mid-career who have made seminal contributions in areas of cancer control that have changed the direction of clinical, psychosocial, behavioral, health policy or epidemiologic cancer research. It is expected that these investigators will continue to provide leadership in their research area. The award also may be used to support similarly qualified individuals who are dedicated to bringing advances in basic sciences into the clinical arena and to articulating clinical problems for basic research scientists. An American Cancer Society Clinical Research Professor is required to be a spokesperson for the American Cancer Society and for cancer research.
Due Dates: Aug. 01 (Letter of Intent)
Invited Applications:  Oct. 13 (OSR) Ι Oct. 15 (Sponsor)
Amount & Project Period: $400,000 - 5 years
Eligibility: Full professor or equiv.
Must not have held rank of full professor or equiv. for more than 15 years
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι Policies Ι proposalCENTRAL 


NEW
August 01 See Below Non-Federal Career Development

American Cancer Society
Audrey Meyer Mars International Fellowship

The purpose is to provide advanced training in clinical oncology at participating cancer centers in the United States to qualified physicians and dentists from other countries, particularly countries where advanced training is not readily available. Moffitt is a participating center.
Due Dates: Jul. 28 (OSR) Ι Aug. 01 (Sponsor)
Paper applications due on Aug. 02
Amount & Project Period: $65,000 - 1 year
Eligibility: Candidate must be  a qualified physician  with a demonstrated an interest in clinical cancer management.
Candidate must be accepted for training by the participating institution and must have fulfilled all requirements of the institution and of the state in which the institution is located. Candidate must be certified by the Education Commission for Foreign Medical Graduates (ECFMG)
Contact: Office of Sponsored Research (x6804)
Link: Overview | Policies | proposalCENTRAL


NEW
August 02, 4:00pm See Below Non-Federal Team Science

Team Science Award

The AACR Team Science Award will recognize an outstanding interdisciplinary research team for its innovative and meritorious science that has advanced or likely will advance our fundamental knowledge of cancer or a team that has applied existing knowledge to advance the detection, diagnosis, prevention, or treatment of cancer.
Due Dates: Aug. 02 (Sponsor)
Amount & Project Period: The team selected to receive the 12th Annual AACR Team Science Award will collectively be awarded a prize of $50,000 and be recognized during the AACR Annual Meeting 2018 in Chicago, Illinois, USA (April 14-18, 2018).
Eligibility: Team is comprised of independent faculty-level researchers providing complementary interdisciplinary expertise, each of whom have made separate substantive and quantifiable contributions to research being recognized.
May be working within same institution or at several institutions; however, if researchers are in same institution, they must have clearly separate funding and research space; Research to be recognized should reflect work towards a specific scientific goal that otherwise would not be realized by any single component of team.
Contact: Questions regarding eligibility of a Team may be directed to AACR's Scientific Achievement Awards office at awards@aacr.org or call (215) 446-7128, prior to submitting a nomination.
Link: proposalCENTRAL (For description, guidelines, and submission of nomination)


August 05 All Ranks Non-federal Mesothelioma

The Meso Foundation
Mesothelioma Research Funding

Eligible projects may relate to benchwork, translational or clinical research not presently funded.  Encouraged projects include: Strategies for early detection and prevention of mesothelioma; Definition of targetable differences between normal and transformed mesothelium and development of novel strategies for treatment taking advantage of these targets; Determination of clinical/molecular determinants for prognosis; and Therapeutic intervention, including: immune response targeted therapy; novel chemotherapeutic compounds; and novel radiation or surgical techniques.
Due Dates: Aug. 03 (OSR) Ι Aug. 05 (Sponsor
Amount & Project Period: $100,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview | proposalCENTRAL


NEW
August 14 (LOI) Junior Faculty Non-Federal Career Development

Arnold and Mabel Beckman Foundation
Beckman Young Investigators Award

Provides research support to the most promising young faculty members in the early stages of their academic careers in the chemical and life sciences, particularly to foster the invention of methods, instruments and materials that will open up new avenues of research in science. Proposed research that cuts across traditional boundaries of scientific disciplines is encouraged. 
Due Dates: Letter of Intent:  Aug. 12 (OSR) Ι  Aug. 14 (Sponsor)
Amount & Project Period: Up to $600,000 (TOTAL) - 4 years
Eligibility: Open to those w/in first 3 years of a tenure-track position, or equiv. independent research appt. Tenure Track Start Date must be after: 8/14/2014.
Candidates must be citizens or permanent residents of the United States at the time of application.
See Beckman Young Investigators Program Information for additional requirements.
Contact: Office of Sponsored Research (x6804)
Link: Beckman Young Investigators


NEW
August 15 All Ranks Non-Federal Gastrointestinal

Hirshberg Foundation for Pancreatic Cancer Research
Seed Grants

The Foundation seeks and supports investigators whose primary intent is to build a strong curriculum in pancreatic cancer research. It is expected that seed grant awards will generate quality abstracts, papers, presentations, as well as new proposals.
Due Dates: Aug. 11 (OSR) Ι Aug. 15 (Sponsor)
Amount & Project Period: Funding is provided on a year-to-year basis in the amount of up to $40,000.  Programs can be extended for one more year upon a competitive renewal/ progress report, which is evaluated by the Advisory Board. 
Eligibility: All Faculty Ranks;
Research scientists and Research Associates w/recommendation from academic faculty supervisor(s); and
Postdocs after two years of completed training in pancreatic cancer research
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι Application



August 15 Postdocs Non-federal Career Development

Damon Runyon Cancer Research Foundation
Fellowship Award

All theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention are encouraged for this fellowship.
Due Dates: Aug. 12 (OSR) Ι Aug. 15 (Sponsor)
Completed applications and USB flash drives must be in sponsor's office by 4:00 pm (ET) on the deadline - NOT postmarked by the due date.
Amount & Project Period: Funding is comprised of a progressive stipend starting at $52,000 and Expense Allowance ($2,000). -  4 years
Note:  Physician-scientists who have completed their residencies and clinical training and are board eligible in the United States will receive Level 2 funding
Eligibility: For degrees conferred between October 15, 2016 and August 15, 2017.
Contact: Office of Sponsored Research (x6071)
Links: Overview Ι Application Guidelines


NEW
August 20 (LOI) All Faculty Non-Federal Clinical Cancer Research

Rising Tide Foundation
Clinical Cancer Research - Cycle 3

The purpose of the program is to advance studies that deliver results for cancer patients and empower individuals to develop their skills to make a difference for themselves and the greater community.  RTF supports truly innovative, unique, patient-centered research that has the potential to positively impact the lives of cancer patients in near future. Early stages clinical studies and translational research that can demonstrate the potential for quick and meaningful impact are funded. Basic research or phase III/IV trials are not supported.
Due Dates: Aug. 20 (Letter of Intent) - If the proposed project meets Rising Tide's funding criteria, an invitation will be extended for submission of a full grant application for further consideration.
Amount & Project Period: The amount of each award is based on the availability of funds. The duration of the award is up to five years or less.
Eligibility: All Faculty
Contact: Office of Sponsored Research - (x6804)
Link: How to apply Ι Program Guidelines


NEW
August 24
(Pre-Application)		 See Below Federal Prostate

Congressionally Directed Medical Research Programs
Prostate Cancer Research Program (PCRP)
Due Dates: Aug. 24 (Pre-application)
Use eBRAP (for pre-application submissions)
Applications Due:  Sept. 05 (OSR) Ι Sept. 07 (Sponsor)
Contact: Office of Sponsored Research (x6804)
 Link: PCRP Program Announcements

Clinical Consortium Award
W81XWH-17-PCRP-CCA

This award mechanism provides the support to develop and enhance collaborations and resources necessary for a network of organizations to rapidly execute Phase II or Phase II-linked Phase I (Phase I/II) prostate cancer clinical trials, including investigations of high-impact, novel therapeutic agents or approaches for the management or treatment of prostate cancer. In accordance with PCRP goals, the conduct of Phase I/II trials incorporating investigations of biomarkers for risk assessment, early detection, prediction of aggressiveness, and/or progression of prostate cancer is particularly encouraged.  Support from this award is directed toward consortium infrastructure needs rather than direct support of the research itself.
Amount & Project Period: Coordinating Center: $3,600,000 (Direct Costs) - 3 years Clinical Research Sites:  $600,000 (Direct Costs) - 3 years Note:  Exercise of options for continued performance for each Clinical Research Site after the first year will be contingent upon meeting performance metrics outlined in program announcement.
Eligibility: PI must be independent investigator at or above Asst. Professor level (or equiv.)
PA Link:  W81XWH-17-PCRP-CCA
 

Prostate Cancer Pathology Resource Network Award
W81XWH-17-PCRP-PCPRNA

 This award mechanism is intended to provide infrastructure support for development and maintenance of a prostate cancer biorepository through a collaborative network across multiple institutions that will facilitate the collection, processing, annotation, storage, and distribution of high-quality human prostate cancer biospecimens.
Amount & Project Period: Combined total direct costs of Initiating PI and all Partnering PIs' awards will not exceed $3.6M direct costs. - 3 Years
Eligibility: PI must be independent investigator at or above Asst. Professor level (or equiv.) with access to appropriate facilities.
PA Link: W81XWH-17-PCRP-PCPRNA




NEW
September 01 All Ranks Non-Federal Clinical Oncology

Hope Foundation
Impact Award

This award is a funding program from the Hope Foundation that encourages novel and innovative SWOG research by supporting early and conceptual stages of such projects. Proposed work should use resources from completed SWOG trials or be directly translatable to future clinical trials in SWOG and the National Clinical Trials Network (NCTN). Studies may involve scientific risk but potentially lead to a breakthrough in a particular area, or to development of novel techniques, agents, methodologies, models, or applications that could have a major impact on cancer research.
Due Dates: Aug. 30 (OSR) Ι Sept. 01 (5:00, pm ET) (Sponsor)
Next Due Date:  March 01, 2018
Amount & Project Period: Up to $250,000 (TOTAL) - 2 years
Eligibility: Any SWOG member investigator eligible for NIH funding is encouraged to submit to this program.
Basic Science applicants are required to partner with a clinician as a Co-PI.
Contact: Office of Sponsored Research (x6804)
Link: Impact Award Ι 2017 RFA
DP1 NIH
NIH Common Fund

NEW
September 01 All Ranks Federal Non-Specific

NIH Director's Pioneer Award Program

This program complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists of exceptional creativity who propose pioneering and possibly transforming approaches to addressing major biomedical or behavioral challenges that have the potential to produce an unusually high impact on enhancing health, lengthening life, and reducing illness and disability. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator's research program or elsewhere.
Due Dates: Aug. 30 (OSR) Ι Sept. 01 (Sponsor)
Amount & Project Period: $700,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks - Only single PD/PI applications are allowed. Applications with multiple PD(s)/PI(s) will not be accepted.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-17-005

NEW
September 07 (LOI) See Below Federal Team Science

Concern Foundation
The Conquer Cancer Now Award

Proposals must be hypothesis-driven and centered on cancer genetics, cancer biology, or cancer immunology. Concern will not fund clinical trials, cancer epidemiology, or behavioral studies.
Due Dates: Aug. 01 (Letter of Intent)
Invited Applications:  Dec. 05 (OSR) Ι Dec. 07 (Sponsor)
Amount & Project Period: $120,000 - 2 years
Eligibility: Junior faculty - independent at the start of scientific career and at level of Asst. Professor (or equiv. with explanation)
Contact: Office of Sponsored Research (x6804)
Link: Grant Guidelines Ι proposalCENTRAL (For description, guidelines, and submissions)
DP2 NIH
NIH Common Fund

NEW
September 08 Junior Faculty Federal Career Development

NIH Director's New Innovator Award Program

This program supports a small number of early stage investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research.
Due Dates: Sept. 06 (OSR) Ι  Sept. 08 (Sponsor)
Amount & Project Period: $1,500,000 (Direct Costs) - 5 years
Due to multi-year funding reporting requirements, projects must end June 30, 2023.
Eligibility: Applicants must meet definition of an Early Stage Investigator (ESI) at time of application.
Applicants must hold an independent research position as of September 1, 2018.
Applicants may submit or have an R01 (or other equivalent) grant application pending concurrently that does not overlap substantially.
However, if that pending grant is awarded prior to the NIH Director's New Innovator Award, then the applicant is no longer eligible to receive the New Innovator Award.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-17-006
R01 NCI

NEW
September 12 (LOI) All Ranks Federal Health Disparities

U.S. Tobacco Control Policies to Reduce Health Disparities

The purpose of this FOA is to support observational or intervention research focused on reducing health disparities in tobacco use in the U.S.  Specifically, it is intended to stimulate scientific inquiry focused on innovative tobacco control policies.
Due Dates: Sept. 12 (Letter of Intent)
Oct. 09 (OSR) Ι Oct. 11 (Sponsor)          
Additional due dates:  June 13, & October 11, 2018
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-17-217
Companion FOA: PAR-17-218 (R21)


NEW
September 13
(Pre-application)		 All Ranks Federal Lung

Congressionally Directed Medical Research Programs
Lung Cancer Research Program (LCRP)
Career Development Award
W81XWH-17-LCRP-CDA

This mechanism supports early-career, independent investigators to conduct impactful research under the mentorship of an experienced lung cancer researcher as an opportunity to obtain the funding, mentoring, and experience necessary for productive, independent careers at the forefront of lung cancer research. This award is intended to support impactful research projects with an emphasis on discovery.
Due Dates: Sept. 13 (Pre-application)
Full Applications Due:  Sept. 25 (OSR) Ι Sept. 27 (Sponsor)
Amount & Project Period: $250,000 (Direct Costs) - 2 years
Eligibility: Must be an independent investigator at the level of Assistant Professor, Instructor, or equivalent w/in 5 years of first faculty appointment (or equiv.) by application submission;. Must have at least 40% of protected time for lung cancer research;
Must not have received a CDMRP Career Development Award (or equiv.) from any program within the CDMRP;
Must not have received more than $300,000 in total direct costs for previous or concurrent lung cancer research as a PI of one or more Federally or privately funded, non-mentored, peer-reviewed grants.
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-LCRP-CDA
R01 NIH

NEW
September 15 All Ranks Federal Non-Specific

NIH Director's Transformative Research Awards

This program complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original and/or unconventional research.  Applications supported under this award will reflect ideas substantially different from mainstream concepts.  Requirements for explicitly addressing specific issues, focuses attention on the importance of the problem, the novelty of the hypothesis and/or the proposed methodology, and the magnitude of the potential impact rather than on preliminary data or experimental details, rather than on preliminary data or experimental details.
Due Dates: Sept. 13 (OSR) Ι Sept. 15 (Sponsor)
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-17-007


NEW
September 19
Noon (Concept Paper)		 Postdocs/Junior Faculty Non-Federal Career Development

Thrasher Research Fund
Early Career Grants 2017 Fall Cycle

The purpose of this program is to encourage the development of medical research in child health by awarding small grants to new researchers, helping them gain a foothold in this important area. There is no focus on a particular disease.
Due Dates: Sept. 19 (Concept paper)
Invited Applications:  Oct. 04 (OSR) Ι Oct. 06 (Sponsor)
Amount & Project Period: $25,000 (Direct Costs) - 1 to 2 years
Eligibility: Physicians in a residency/fellowship training program or have completed program < 1 year before date of submission of Concept Paper.
Post-docs who received doctoral level degree < 3 years prior date of submission of Concept Paper.
A new investigator who holds an NIH K award or a CTSA is not eligible.
There are no restrictions with regard to citizenship.
Mentors may have only one Thrasher Research Fund Early Career Awardee at a time.
Contact: Office of Sponsored Research (x6804)
Link: Early Career Awards
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org